DGX
Quest Diagnostics, Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$246.48
−0.39%Forward multiples
Based on analyst estimates
- P/E forward
- 21.47x
- P/E 2026E
- 22.08x
- P/E 2027E
- 20.50x
- P/E 2028E
- 18.87x
- P/S forward
- 2.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- 25.84x
- PEG TTM
- 1.27x
- Price / book
- 3.62x
- Price / sales
- 2.35x
- Price / cash flow
- 15.34x
Enterprise value
- Enterprise value
- $33.3B
- EV / sales
- 2.88x
- EV / EBITDA
- 16.57x
- EV / EBIT
- 20.35x
- Market cap
- $27.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026